SCHEMBL26435491

SCHEMBL26435491

c1cc(-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-c3cc4ccccc4c4ccccc34)n2)cc(-c2cccc3ccc4ccccc4c23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALOX5 P09917 1/20 0.35
HCRTR1 O43613 1/20 0.34
ALDH1A1 P00352 4/20 0.34
AHR P35869 3/20 0.34
HPGD P15428 3/20 0.34
TSHR P16473 2/20 0.34
CASP1 P29466 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 2/20 0.34
FYN P06241 2/20 0.34
ERBB2 P04626 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
KDM4E B2RXH2 3/20 0.34
MAPT P10636 3/20 0.34
DUSP3 P51452 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435204 0.94 L3MBTL1 (0.38) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26435464 0.92 TDP1 (0.38) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26435216 0.90 L3MBTL1 (0.36) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26435472 0.90 TDP1 (0.36) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26435510 0.90 ALDH1A1 (0.39) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL23821048 0.89 ALOX5 (0.36) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26435511 0.89 KDM4E (0.39) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26047916 0.88 AHR (0.39) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26435199 0.88 TDP1 (0.42) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL26435561 0.88 ALOX5 (0.43) L3MBTL1TDP1ALOX5ALDH1A1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 L3MBTL1 1536/4885TDP1 1017/4885ALOX5 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.